Skip to content
drillr.ai

AIRS

AirSculpt Technologies, Inc.

NASDAQ · USHealthcareMedical - Care Facilities
$4.78+7.42%

Price as of Jul 20, 2026

AIRS news

AirSculpt Technologies, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. AirSculpt Technologies Reports First Quarter Fiscal 2026 Results

    MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. Yogi Jashnani, Chief Executive Officer, stated: “We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet in the first quarter. Our performance marks a key turning point fo

    Globe Newswire ·

  2. AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results

    MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (

    Globe Newswire ·

  3. CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results

    MIAMI BEACH, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 2nd, 2026, by AirSculpt Technologies, Inc. (NASDAQ:AIRS), please note that the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income. The updated release reflects the updated figures. AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt

    Globe Newswire ·

  4. AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results

    MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2025. Yogi Jashnani, Chief Executive Officer, stated: “In the fourth quarter, we delivered sequential improvement in same store sales versus the first nine months of the year and adjusted EBITDA ahead of the prior year period,” s

    Globe Newswire ·

  5. AirSculpt Technologies Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call

    MIAMI BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter and fiscal year 2025 financial results before market open on Thursday, April 2, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (inte

    Globe Newswire ·

  6. AirSculpt Technologies Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

    SAN DIEGO, March 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of AirSculpt Technologies, Inc. (NASDAQ: AIRS). The investigation focuses on AirSculpt Technologies executive officers and whether investor losses may be recovered under federal securities laws. What if I purchased AirSculpt Technologies securities? If you purchased AirSculpt Technologies securities and suffered losses on your investment, join our investigation now: Click h

    Globe Newswire ·

  7. AirSculpt Technologies Announces Its Intent to Delay the Filing of its Annual Report and Provides Business Update

    Preliminary Fiscal Year 2025 Revenue of $151.8 Million Refreshed Marketing Strategy Delivers Positive Same-Store Sales in February 2026 Strong Balance Sheet and Enhanced Liquidity MIAMI BEACH, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced that it expects to file a Form 12b-25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about March

    Globe Newswire ·